The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials

Published:2023-09 Issue:3 Volume:118 Page:614-626
ISSN:0002-9165
Container-title:The American Journal of Clinical Nutrition
language:en
Short-container-title:The American Journal of Clinical Nutrition

Author:

Liu Yupeng,Ruan Binye,Jiang Huinan,Le Siyu,Liu Yi,Ao Xuemei,Huang Yufeng,Shi Xudong,Xue Ru,Fu Xiaoyi,Wang Shuran^ORCID

Funder

Wenzhou Medical University

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Reference68 articles.

1. ABC of obesity. Risk factors for diabetes and coronary heart disease;Wild;BMJ,2006

2. The pathophysiology of hypertension in patients with obesity;DeMarco;Nat. Rev. Endocrinol.,2014

3. Obesity and dyslipidemia;Howard;Endocrinol. Metab. Clin. North. Am.,2003

4. Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight loss;Artham;Ochsner. J.,2009

5. Cancer incidence and mortality in relation to body mass index in the million women study: cohort study;Reeves;BMJ,2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing disease treatment through bioengineered probiotics and glucagon‐like peptide 1 (GLP‐1) based strategies: A path towards effective cures;Food Bioengineering;2024-09-04

2. Obesity in adults;The Lancet;2024-09

3. Metabolic bariatric surgery, alcohol misuse and liver cirrhosis: a narrative review;Metabolism and Target Organ Damage;2024-08-26

4. Long‐term safety and efficacy of glucagon‐like peptide‐1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study;Diabetes, Obesity and Metabolism;2024-08-22

5. Mortality and Serious Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists: A Pharmacovigilance Study Using the FDA Adverse Event Reporting System;Cureus;2024-08-02